Healio Blog Update: The role of haploidentical bone marrow transplant for severe aplastic anemia
A new blog post from Dr. Phuong T. Vo highlights two groundbreaking trials that are reshaping treatment options for patients with severe aplastic anemia — especially those without fully matched donors. The use of haploidentical bone marrow transplantation (BMT), paired with post-transplant cyclophosphamide-based GVHD prophylaxis, could significantly expand access and improve outcomes.
“Advances in preventing graft-versus-host disease and the availability of haploidentical donors could transform aplastic anemia.”
— Phuong T. Vo, MD